Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-01 Sale |
2022-12-02 5:00 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
865 | $22.95 | $19,852 | 6,629 (Direct) |
View |
| 2022-10-28 Sale |
2022-11-01 5:00 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
10,000 | $39.9 | $399,000 | 93,624 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 5:00 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
60,000 | $35.34 | $2,120,392 | 126,822 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-22 5:00 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
20,000 | $34.9 | $698,000 | 8,228 (Direct) |
View |
| 2022-07-13 Sale |
2022-07-15 5:00 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
10,000 | $24.9 | $249,000 | 143,624 (Direct) |
View |
| 2021-12-22 Sale |
2021-12-27 6:12 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
15,000 | $38.7 | $580,469 | 151,995 (Direct) |
View |
| 2021-06-21 Purchase |
2021-06-21 6:21 pm |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
5,000 | $19 | $95,000 | 26,599 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 5:00 pm |
N/A 2033-02-13 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
182,800 | $0 | 182,800 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 5:00 pm |
N/A 2030-09-15 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
36,000 | $0 | 222,623 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
36,000 | $2.87 | 222,623 (Direct) |
View |
| 2022-10-28 Exercise |
2022-11-01 5:00 pm |
N/A 2029-09-16 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
10,000 | $0 | 93,624 (Direct) |
View |
| 2022-10-28 Exercise |
2022-11-01 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
10,000 | $1.48 | 93,624 (Direct) |
View |
| 2022-09-23 Exercise |
2022-09-27 5:00 pm |
N/A 2029-09-16 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
60,000 | $0 | 126,822 (Direct) |
View |
| 2022-09-23 Exercise |
2022-09-27 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
60,000 | $1.48 | 126,822 (Direct) |
View |
| 2022-07-20 Exercise |
2022-07-22 5:00 pm |
N/A 2029-06-24 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
20,000 | $0 | 8,228 (Direct) |
View |
| 2022-07-20 Exercise |
2022-07-22 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
20,000 | $1.39 | 8,228 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 5:00 pm |
N/A 2029-09-16 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
10,000 | $0 | 143,624 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO |
10,000 | $1.48 | 143,624 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 08:57 am |
N/A 2032-02-10 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-27 6:12 pm |
N/A 2029-09-16 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
15,000 | $0 | 151,995 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-27 6:12 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
15,000 | $1.48 | 151,995 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-17 4:41 pm |
N/A 2031-12-15 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:21 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
21,599 | $0 | 26,599 (Direct) |
View |
Ownership |
2021-06-16 7:34 pm |
N/A 2031-02-11 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
0 | $0 | 550,783 (Direct) |
View |